Allergan Aesthetics Launches Fourth Year of The Confidence Collective

Allergan Aesthetics, an AbbVie company, has opened applications for the fourth year of The Confidence Collective, a BOTOX^® Cosmetic-branded initiative focused on supporting women entrepreneurs, according to company-provided materials. The application window is open through April 29, 2026, with submissions due by 11:59 pm PT.

According to the announcement, the 2026 program will provide 250 women entrepreneurs with access to coaching, business resources, and peer community. From that group, 20 participants are expected to receive $20,000 grants. Allergan Aesthetics said the program is intended to address persistent barriers facing women business owners, including gaps in financial literacy support, access to capital networks, and formal mentorship.

Nicole Mowad-Nassar, President of Global Allergan Aesthetics and Senior Vice President at AbbVie, said the initiative is designed to help entrepreneurs build sustainable growth through mentoring, coaching, funding, and community support. 

The company also included a testimonial from 2025 participant and grant recipient Saria Hawkins-Banda, who described the program as a catalyst for business growth and leadership development.

"Receiving the $20,000 grant was truly a dream come true. The program pushed me to grow in ways I never imagined. I strengthened my skills, built my confidence as an entrepreneur, and was surrounded by a community of bold, inspiring women who genuinely wanted to see each other succeed," said Saria Hawkins-Banda, She-EO at Manifest Your Purpose. "Participating in this program wasn't just about the funding; it was a launchpad for my business and my vision for the future. I'm deeply grateful to this program for believing in me, and I'm excited to pay that support forward by uplifting and championing the next class of women founders."

BOTOX^® Cosmetic is the brand name for onabotulinumtoxinA and is marketed by Allergan Aesthetics for temporary improvement in the appearance of moderate to severe forehead lines, glabellar lines, and lateral canthal lines in adults. The current announcement, however, centers on a brand-led entrepreneurial grant program rather than a clinical development, regulatory, or practice-management update.